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Abstract. 
 
We describe here a novel sarcomeric 145-
 
kD protein, myopalladin, which tethers together the
COOH-terminal Src homology 3 domains of nebulin
 
and nebulette with the EF hand motifs of 
 
a
 
-actinin
in vertebrate Z-lines. Myopalladin’s nebulin/nebulette
 
and 
 
a
 
-actinin–binding sites are contained in two dis-
tinct regions within its COOH-terminal 90-kD domain.
Both sites are highly homologous with those found in
palladin, a protein described recently required for actin
 
cytoskeletal assembly (Parast, M.M., and C.A. Otey.
 
2000. 
 
J. Cell Biol.
 
 150:643–656). This suggests that palla-
din and myopalladin may have conserved roles in stress
 
ﬁber and Z-line assembly. The NH
 
2
 
-terminal region of
myopalladin speciﬁcally binds to the cardiac ankyrin re-
peat protein (CARP), a nuclear protein involved in con-
trol of muscle gene expression. Immunoﬂuorescence and
 
immunoelectron microscopy studies revealed that myo-
palladin also colocalized with CARP in the central I-band
of striated muscle sarcomeres. Overexpression of myo-
 
palladin’s NH
 
2
 
-terminal CARP-binding region in live
cardiac myocytes resulted in severe disruption of all
sarcomeric components studied, suggesting that the
myopalladin–CARP complex in the central I-band may
have an important regulatory role in maintaining sarco-
meric integrity. Our data also suggest that myopalladin
may link regulatory mechanisms involved in Z-line
structure (via 
 
a
 
-actinin and nebulin/nebulette) to those
involved in muscle gene expression (via CARP).
Key words:
 
a
 
-actinin • nebulin • palladin • myopalla-
din • CARP
 
Introduction
 
The precise organization of Z-lines, the borders of individual
 
sarcomeres in vertebrate striated muscle, is a remarkable ex-
 
ample of supramolecular assembly in eukaryotic cells.
Z-lines contain the barbed ends of actin thin filaments, the
 
NH
 
2
 
-terminal ends of titin filaments, the COOH-terminal
ends of nebulin filaments (skeletal muscle), and nebulette
(cardiac muscle), as well as a variety of other regulatory
and structural proteins. In addition to being a boundary
between successive sarcomeres, Z-lines are responsible for
transmitting tension generated by individual sarcomeres
along the length of the myofibril, allowing for efficient
contractile activity (for discussion see Vigoreaux, 1994;
Squire, 1997). Z-line–associated proteins also appear to be
crucial for early stages of myofibril assembly since I-Z-I
structures (i.e., Z-line precursors) form the earliest identifi-
able protein assemblies observed during muscle differentia-
tion (Epstein and Fischman, 1991; Holtzer et al., 1997; Ehler
et al., 1999; Ojima et al., 1999; Gregorio and Antin, 2000).
Thus, deciphering the molecular interactions of proteins
forming Z-lines is pivotal for understanding the regulation of
myofibril assembly, sarcomeric organization, and mechanical
properties of striated muscle.
 
Detailed ultrastructural and biochemical investiga-
tions of the Z-disc and its various components have
yielded valuable information concerning its structural ar-
 
chitecture. The width of the Z-line can vary from 
 
z
 
30 nm
 
in fish skeletal muscle, up to 
 
.
 
1 
 
m
 
m in patients with cer-
tain forms of nemaline myopathy (Franzini-Armstrong,
1973; Rowe, 1973; Yamaguchi et al., 1985; Vigoreaux,
1994). The thin filaments from adjacent sarcomeres fully
overlap within the Z-line and are cross-linked by the di-
rect interaction of actin filaments and the actin filament
 
barbed end–capping protein, CapZ, with 
 
a
 
-actinin (Goll
 
et al., 1972; Papa et al., 1999). Both the NH
 
2
 
-terminal re-
gion of titin and the COOH-terminal region of nebulin
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are also integral components of the Z-line lattice. Titin
filaments from adjacent sarcomeres fully overlap in the
Z-lines (Gregorio et al., 1998; Young et al., 1998). In
vitro studies have identified two distinct 
 
a
 
-actinin–bind-
ing sites within titin’s NH
 
2
 
-terminal, 80-kD, Z-disc inte-
gral segment. These binding sites (the Z-repeats and
titin’s NH
 
2
 
-terminal sequences adjacent to the Ig-repeat
Z4), may link together titin and 
 
a
 
-actinin filaments both
inside the Z-line and at its periphery (Ohtsuka et al.,
1997; Sorimachi et al., 1997; Gregorio et al., 1998;
Young et al., 1998). The 
 
z
 
50-kD COOH-terminal re-
gion of nebulin also extends into the Z-line lattice in
skeletal muscle: the Src homology (SH)
 
1 
 
3 domain of
nebulin is localized 
 
z
 
25 nm inside the Z-line, whereas
the more NH
 
2
 
-terminal repeating modules of nebulin
are located at the periphery of the Z-line (Millevoi et
al., 1998). Although cardiac muscle does not appear to
contain nebulin, it contains a smaller, nebulin-related
protein, nebulette (Moncman and Wang, 1995). Nebu-
lette is highly homologous to the COOH-terminal re-
gion of nebulin and it also extends into the Z-line. It has
been suggested that this homology between nebulin and
nebulette reflects conserved roles for their COOH-ter-
minal ends in Z-line integration (Moncman and Wang,
1995; Millevoi et al., 1998).
To date, the molecular interactions that are responsi-
ble for anchoring nebulin and nebulette filaments inside
Z-lines are unknown, although previous models have
proposed potential direct interactions between nebulin/
nebulette and 
 
a
 
-actinin (Nave et al., 1990; Moncman
and Wang, 1999). Here, we have used the yeast two-
hybrid system to search for components that interact
with the COOH-terminal (intra–Z-line) region of nebu-
lin and thereby anchor it within the sarcomere. This ap-
proach identified a direct interaction between the
Z-line peripheral region of nebulin and the intermediate
filament protein, desmin; this link may contribute to the
lateral connections between adjacent Z-lines. We also
identified a novel 145-kD protein, myopalladin, that in-
teracts with both the intra–Z-line, SH3 domain of nebu-
lin and with 
 
a
 
-actinin’s EF hand region. Our in vitro
binding data predict that myopalladin tethers the nebu-
lin (directly), titin, and thin filaments (indirectly) via
 
a
 
-actinin filaments, thereby forming intra–Z-line mesh-
works. Additionally, we found that the NH
 
2
 
-terminal
region of myopalladin interacts with the cardiac ankyrin
repeat protein (CARP) (Chu et al., 1995; Baumeister et
al., 1997; Jeyaseelan et al., 1997; Zou et al., 1997) within
the I-band, an inducible protein implicated in the con-
trol of muscle gene expression (Zou et al., 1997). Our
binding, immunolocalization, and cellular targeting
data, together with the severe disruption of all sarco-
meric components observed by the overexpression of
NH
 
2
 
-terminal myopalladin fragments in live cardiac
myocytes, suggest that myopalladin has important regu-
latory roles in the maintenance of sarcomere structure.
 
Materials and Methods
 
Yeast Two-Hybrid Interaction Studies
 
For a survey of potential nebulin and myopalladin interactions, cDNA
fragments were amplified from rabbit psoas and human skeletal muscle
cDNA by PCR (Saiki et al., 1985). The nebulin M160-M185
 
1
 
Ser
 
1
 
SH3
cDNA sequence was amplified with the primer pair 5
 
9
 
-tttgaattc CCT
GAC ACC CCT CAG ATC CTC CTG GCA AAG and 3
 
9
 
-tttggatccc
TCC TGC AGA CAG GTG TAA TAC TTG TAA GTA. For details on
PCR conditions, see Centner et al. (2000). Amplified PCR fragments were
inserted into pAS2-1 (Matchmaker system II; CLONTECH Laboratories,
Inc.) or BTM117c (Wanker et al., 1997) vectors to obtain GAL4-BD or
LexA-BD fusions, respectively. For screening, bait constructs were trans-
formed into 
 
Saccharomyces cerevisiae
 
, strain CG1945 (pAS2-1 bait) or
L40c (BTM117c bait). Subsequently, the cells were transformed with a
human skeletal muscle cDNA library in the pGAD10 prey vector
(HL4010AB; CLONTECH Laboratories, Inc.) essentially as described by
the manufacturer. Cells were plated onto SD/Leu-/Trp-/His-plates and in-
cubated at 30
 
8
 
C until colonies appeared (after 
 
z
 
5 d). In screens where the
pAS2-1 bait vector was used, the plates were supplemented with 1,5 mM
3-amino-1,2,4-triazole (3-AT; Sigma-Aldrich).
Transformants were picked, restreaked onto SD/Leu-/Trp-/His-plates,
and screened for 
 
b
 
-galactosidase activity. 
 
b
 
-Galactosidase activity of the
cells was measured either by colony lift filter assays using X-gal or in liq-
uid culture using chlorophenol red-
 
b
 
-
 
D
 
-galactopyranoside (cPRG) as de-
scribed by the manufacturer (CLONTECH Laboratories, Inc.). 
 
b
 
-Galac-
tosidase–positive colonies were processed to loosen the bait plasmid, and
prey clones were recovered by electroporation of yeast DNA in 
 
Esche-
richia coli
 
 and sequenced. To further confirm binding, transformants were
retransformed into yeast with either the bait or the vector. In addition, the
inserts of the bait and the prey vector were swapped and cotransformed
into yeast.
For 
 
a
 
-actinin–myopalladin interaction studies, a previously described
 
a
 
–actinin-2 deletion series in the pGAD424 vector was used (Sorimachi et
al., 1997). Furthermore, the COOH-terminal part of 
 
a
 
–actinin-3 contain-
ing two 4-EF hands cloned in pGAD10 was used (provided by Alan
Beggs, Children’s Hospital, Boston, MA). The sequence of all constructs
was verified by sequencing.
 
cDNA Cloning and Sequence Analysis
 
The identified myopalladin prey cDNA corresponded to a 780-bp partial
cDNA clone. The partial myopalladin cDNA was labeled randomly with
 
32
 
P (Optiprime kit; Stratagene) and hybridized to a human heart cDNA li-
brary (number 936208; Stratagene). From a total of 400,000 screened
clones, 
 
z
 
80 clones hybridized to the probe. 24 myopalladin-positive
phages were randomly picked and characterized by PCR, using combina-
tions of specific internal primers and vector arm–derived primers. Clones
extending 1–2 kb into the 5
 
9
 
 and 3
 
9
 
 directions were selected for sequenc-
ing. In total, three fragments extending towards the 5
 
9
 
 end, and one frag-
ment extending towards the 3
 
9
 
 end provided a 5,696-bp cDNA. The pres-
ence of 5
 
9
 
 and 3
 
9
 
 untranslated regions, a putative start ATG at the 5
 
9
 
 end,
and polyadenylation at the 3
 
9
 
 end indicated that the 5.7 kb cDNA corre-
sponded to the complete myopalladin message (see Fig. 4 A). The com-
plete myopalladin coding sequence was also amplified from a human
skeletal muscle cDNA library by PCR (HL4010AB; CLONTECH Labo-
ratories, Inc.) and sequenced. No sequence differences between cardiac
and skeletal myopalladin were observed. All myopalladin fragments were
sequenced on both DNA strands. Reads were edited and assembled using
Geneskipper v1.2 software (Christian Schwager, European Molecular Bi-
ology Laboratory). For sequence analysis, Ig-I repeats were aligned using
ClustalX (Higgins et al., 1996). Insertions were introduced to optimize the
alignments. The complete myopalladin cDNA sequence from human
heart and skeletal muscle is available from EMBL/GenBank/DDBJ under
accession number AF328296.
 
Protein Expression and Antibody Production
 
For obtaining specific antibodies against myopalladin and palladin, resi-
dues 264–430 and 1168–1320 of myopalladin and residues 301–385 of pal-
ladin (EMBL/GenBank/DDBJ accession number AB023209; see Fig. 4
for location of epitopes) were expressed as His
 
6
 
-tagged fusion proteins in
the pET9D vector (Studier and Moffatt, 1986). For generating antibodies
against CARP, the NH
 
2
 
-terminal 93 residues of CARP were fused to His
 
6
 
1
 
Abbreviations used in this paper: 
 
CARP, cardiac ankyrin repeat protein;
GFP, green fluorescent protein; GST, glutathione 
 
S
 
-transferase; SH, Src
homology. 
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in the pET9D vector. Protein expression and purification were performed
essentially as described (Studier et al., 1990). Polyclonal antibodies were
raised in rabbits by Eurogentec and the specific IgG fraction was isolated
by affinity chromatography. Western blot analysis was used to verify the
specificity of the antibodies (see below).
 
In Vitro Transcription/Translation and 
GST Pull-down Experiments
 
In vitro transcription and translation were carried out in the presence of
[
 
35
 
S]methionine (Amersham Pharmacia Biotech) using a TNT T7-cou-
pled reticulocyte lysate system according to the manufacturer’s instruc-
tions (Promega). His
 
6
 
–glutathione 
 
S
 
-transferase (GST) double-tagged fu-
sion proteins were obtained by cloning into a modified pET9D vector.
The constructs were transformed into BL21-DE3 (CLONTECH Labora-
tories, Inc.) cells. Whole cell lysates in coating buffer (2
 
3 
 
PBS, 1% Triton
X-100) were prepared as described previously (Studier et al., 1990). The
GST fusion protein was immobilized on glutathione-Sepharose 4B beads
(Amersham Pharmacia Biotech) by incubating 
 
z
 
200 
 
m
 
l of the lysate with
50 
 
m
 
l of beads (50% slurry) for 1 h at 4
 
8
 
C. The beads were washed three
times with coating buffer and resuspended in binding buffer (20 mM Tris,
pH 7.4, 100 mM KCl, 1 mM EDTA, 1% Triton X-100, plus protease in-
hibitors). 5 
 
m
 
l of in vitro–translated 
 
35
 
S-labeled proteins were added to 50
 
m
 
l of beads coated with 20 
 
m
 
g of bound GST fusion proteins in 300 
 
m
 
l
binding buffer. The mixture was incubated for 1.5 h at 4
 
8
 
C, washed three
times with binding buffer, and resuspended in SDS sample buffer. The
protein complexes were fractionated by SDS-PAGE using 15% gels. The
gels were fixed (20% methanol, 10% acetic acid), stained with Coomassie
blue, treated with Amplify (Amersham Pharmacia Biotech), dried, and
exposed using BioMax MR-1 film (Eastman Kodak Co.). The results of
the Coomassie blue staining confirmed that equal amounts of each GST
protein were bound to the beads in the different samples (data not
shown).
 
Northern and Western Blot Analysis
 
For determining myopalladin and palladin’s tissue-specific transcription,
the full-length coding sequence of myopalladin and the subfragment
bp 1289–4172 of palladin (EMBL/GenBank/DDBJ accession number
AB023209) was randomly labeled with 
 
32
 
P using the Prime-It RmT kit
(Stratagene) and purified on a NucTrap column (Stratagene). The myo-
palladin-specific probe was hybridized to a multiple tissue Northern blot
(CLONTECH Laboratories, Inc.) as described by the manufacturer. For
protein expression analysis, Western blots were probed with rabbit affin-
ity-purified antimyopalladin, antipalladin, and anti-CARP polyclonal
antibodies essentially as described previously (Gregorio et al., 1995).
Snap-frozen heart, skeletal, or smooth muscle was ground in liquid ni-
trogen into a fine powder using a mortar and pestle. The muscle powder
was solubilized in 2
 
3
 
 SDS sample buffer, boiled for 5 min, and soni-
cated. Solubilized proteins were fractionated by SDS-PAGE using 8%
gels and transferred to a nitrocellulose membrane. 0.5 
 
m
 
g/ml of affinity-
purified rabbit antimyopalladin-1 IgG was used to probe rabbit heart,
soleus, and psoas muscle lysates. 2.0 
 
m
 
g/ml of affinity-purified rabbit an-
tipalladin IgG was used to probe rat heart, psoas, and small intestine
(source of smooth muscle) lysates. 1.0 
 
m
 
g/ml of affinity-purified rabbit
anti-CARP IgG was used to probe rat heart lysates. Primary antibody
incubations were followed by HRP-conjugated goat anti–rabbit IgG
(1:25,000; Jackson ImmunoResearch Laboratories). Both primary and
secondary antibody incubations were for 1 h at 4
 
8
 
C. The blots were incu-
bated in Super Signal chemiluminescent substrate (Pierce Chemical Co.)
according to the manufacturer’s instructions and exposed to Biomax MR
film (Eastman Kodak Co.).
 
Cell Culture and Transfection Procedures
 
For myocyte expression studies, the entire myopalladin open reading
frame (bp 488–4450) and subfragments 488–1327, 488–2254, 1789–3299,
and 3300–4450 (see Fig. 3) were amplified by PCR and cloned into
pEGFP-C1 (CLONTECH Laboratories, Inc.). Recombinant pEGFP-C1
constructs were purified using QIAGEN columns before transfection into
myocytes. Plasmids were verified by sequencing. To rule out any potential
artifacts resulting from the green fluorescent protein (GFP) tag, pCMV-
myc-myopalladin constructs were also generated (as in Gregorio et al.,
1998) and tested in overexpression studies: identical results were obtained
(data not shown).
 
Cardiac myocytes were prepared from day 6 embryonic chick hearts
and cultured as described previously (Gregorio and Fowler, 1995). Iso-
lated cells were plated in 35-mm tissue culture dishes containing 12-mm
round coverslips (10
 
6 
 
cells/dish). 15–20% of the cells in our primary cul-
tures are fibroblasts. 24 h after plating, cultured myocytes were washed
two times in OptiMEM, placed in 800 
 
m
 
l fresh OptiMEM, and returned to
the incubator while DNA liposome complexes were prepared. DNA lipo-
some complexes were prepared by combining 0.5 or 1 
 
m
 
g plasmid with 4
 
m
 
l LipofectAmine and 6 
 
m
 
l PLUS Reagent in 200 
 
m
 
l serum-free Opti-
MEM. After 15 min, the complexes were added dropwise to the culture
dish. 3 h later, 1 ml of MEM/10% FBS (Hyclone Laboratories, Inc.) was
added to the dish. 3–6 d later, cells were gently washed with PBS and fixed
with 2% formaldehyde in PBS for 10 min. Coverslips were washed and
stored in PBS at 4
 
8
 
C until staining. Over 200 transfected cells per con-
struct were analyzed. Our transfection efficiencies ranged from 10 to 50%.
All tissue culture reagents (except where noted) were purchased from
Life Technologies.
 
Immunoelectron Microscopy
 
Cardiac muscles were dissected from the left ventricular wall of hearts
rapidly excised from 8–9-wk-old mice (Balb/C). Muscle strips were
skinned in relaxing solution containing 1% vol/vol Triton X-100 overnight
at 4
 
8
 
C. After extensive washing with relaxing solutions, the muscles were
fixed in 3% formaldehyde/PBS solution, blocked for 1 h with PBS supple-
mented with 1% BSA, and labeled with the primary antibodies (typically
50 
 
m
 
g/ml), followed by washing. Affinity-purified Fab
 
9
 
 fragments, raised
in goat against the whole rabbit IgG molecule, were used as secondary an-
tibodies (no. 2004; Nanoprobes, Inc.). Secondary antibodies were conju-
gated with 1.4-nm gold particles and were further intensified with HQ sil-
ver developer for 4 min. For more details, see Trombitás et al. (1995) and
Gregorio et al. (1998). Z-disc–to-epitope distances were measured from
electron micrographs after high-resolution scanning (UC-1260; UMAX
Data System, Inc.) as described in Gregorio et al. (1998).
 
Indirect Immunofluorescence Microscopy
 
Rat cardiac and skeletal muscle myofibrils were isolated and washed ac-
cording to Knight and Trinick (1982), as modified by Fowler et al. (1993).
Primary cultures of rat cardiac myocytes were isolated and maintained as
described (Gustafson et al., 1987). Myofibrils attached to poly-
 
D
 
-lysine
(Sigma-Aldrich) coated coverslips were fixed in 2% formaldehyde/PBS
for 10 min, washed in PBS, and permeabilized in 0.2% Triton X-100/PBS
for 15 min. The coverslips were preincubated in 2% BSA, 1% normal
donkey serum/PBS for 1 h to minimize nonspecific binding of antibodies.
Isolated myofibrils and cells were incubated with affinity-purified rabbit
polyclonal antibodies specific to myopalladin, palladin, or CARP (5–10
 
m
 
g/ml
 
1
 
), followed by Cy-2–conjugated goat anti–rabbit IgG (1:600). For
double-labeling protocols, myofibrils and cells were also incubated with
antimyomesin monoclonal antibodies (1:20; provided by Perriard, J.-C.,
and E. Ehler (Institute for Cell Biology, Zurich, Switzerland; Grove et al.,
1985), followed by Texas red–conjugated goat anti–mouse IgG
 
1
 
IgM
(1:600). To confirm the location of precursor I-Z-I (i.e., precursor Z-lines/
stress-fiber–like) structures in cultured cardiac myocytes, cells were also
double-stained with Texas red–conjugated phalloidin (data not shown).
Transfected cardiac myocytes were essentially stained as described
(Gregorio et al. 1998). Six well-characterized antibodies specific to various
sarcomeric components and phalloidin were used to analyze sarcomeres
in transfected cells. The transfected cells were stained with monoclonal
sarcomeric anti–
 
a
 
-actinin antibodies (1:1,500, EA-53; Sigma-Aldrich) or
rabbit polyclonal 
 
a
 
-actinin antibodies (1:2,000; provided by Dr. S. Craig,
Johns Hopkins University, Baltimore, MD), antititin T11 monoclonal an-
tibodies (1:1,000; Sigma-Aldrich), monoclonal antimyomesin B4 antibod-
ies (1:20; see above), or Texas red–conjugated phalloidin (Molecular
Probes, Inc.) for 1 h and washed in PBS. Subsequently, the cells were
stained with Texas red–conjugated goat anti–mouse IgG
 
1
 
IgM (1:600) or
Texas red–conjugated donkey anti–rabbit antibodies (1:700) for 45 min.
All coverslips were mounted on slides using Aqua Poly/Mount (Poly-
sciences, Inc.) and subsequently analyzed on an Axiovert microscope
(ZEISS) using 63
 
3 
 
(NA 1.4) or 100
 
3
 
 (NA 1.3) objectives, and micro-
graphs were recorded as digital images on a SenSys cooled HCCD (Photo-
metrics). Images were processed for presentation using Adobe Photo-
shop
 
®
 
 5.0. All secondary antibodies were purchased from Jackson
ImmunoResearch Laboratories, except the Cy2-conjugated antibodies
that were purchased from Pierce Chemical Co. 
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Results
 
Interaction of the COOH-terminal Region of Nebulin 
with Desmin and Myopalladin
 
To search for proteins interacting with the Z-disc region of
nebulin, a fragment corresponding to its COOH-terminal
2,687 kb was amplified from rabbit psoas skeletal muscle
and inserted into the yeast two-hybrid bait vector pAS2-1.
The bait, referred to as pAS2-M160-M185
 
1
 
Ser
 
1
 
SH3, in-
cluded the nebulin repeats, M160–M176 and M182–M185,
the Ser-rich region, and the SH3 domain (Fig. 1). The neb-
ulin repeats M177–M181 are absent from rabbit psoas
muscle nebulin (Millevoi et al., 1998). When screening
700,000 clones from a human skeletal library with pAS2-
M160-M185
 
1
 
Ser
 
1
 
SH3, 
 
.
 
1,000 potentially interacting
clones were identified. From these, 100 clones were ran-
domly picked and analyzed for 
 
b-galactosidase expression.
12 clones with the highest levels of b-galactosidase expres-
sion were sequenced. One clone corresponded to a partial
cDNA, which encoded one Ig repeat and was derived from
a palladin-homologous gene (Parast and Otey, 2000) de-
scribed here as “myopalladin.” The full-length cDNA se-
quence of myopalladin was obtained by the screening of
both human skeletal and heart muscle cDNA libraries and
performing extensions to reach the 59 and 39 end. This
identified a 5.7-kb full-length cDNA for myopalladin (see
Materials and Methods), which contains a single open
reading frame and encodes a protein of 1,320 amino acids
with a predicted molecular mass of 145 kD (see Fig. 4 A).
We found no evidence for differentially spliced myopalla-
din isoforms in heart and skeletal muscle (not shown).
Another clone corresponded to the intermediate fila-
ment protein, desmin (Vicart et al., 1996). The remaining
10 prey clones were devoid of open reading frames, or cor-
responded to ribosomal and nuclear proteins. Therefore,
we assumed that a large amount of prey clones identified
in this screen corresponded to false positive clones.
Subsequently, we performed yeast two-hybrid screens
with subfragments of pAS2-M160-M1851Ser1SH3. pAS2-
M160-M183 (Fig. 1) identified 23 prey clones from the
screening of 800,000 clones. 21 of the prey clones corre-
sponded to desmin (Vicart et al., 1996), thus confirming
the interaction identified in the initial screen with pAS2-
M160-M1851Ser1SH3 (Fig. 1). Further analysis of des-
min and nebulin’s interaction will be presented elsewhere
(Bang, M.-L., and S. Labeit, manuscript in preparation). In
screenings performed with pAS2-M184-M1851Ser1SH3,
as well as pAS2-SH3 (Fig. 1), a high frequency of prey
clones was identified, suggesting that the presence of the
nebulin SH3 domain in the bait was responsible for the
high occurrence of false positives in the first screen. There-
fore, our clones, in particular those interacting with pAS2-
SH3 in the two-hybrid system, were analyzed in detail by
GST pull-down assays. The interaction of nebulin Ser-SH3
with myopalladin was confirmed by GST pull-down assays
(see Fig. 4 D).
In summary, we conclude that the COOH-terminal end
of nebulin, which is located z25 nm inside the Z-line lat-
tice, specifically interacted with the novel 145-kD sarco-
meric protein, myopalladin. Studies in progress are fo-
cused on characterizing further the interaction of nebulin
M160–M183, shown previously to be located in the periph-
ery of the Z-line (Millevoi et al., 1998), with desmin.
Analysis of Myopalladin’s Primary Structure and Its 
Expression Patterns
Analysis of the primary structure of myopalladin revealed
the presence of five Ig domains from the Ig-I subset (Har-
paz and Chothia, 1994; designated I–V in Fig. 2 A) in its
1,320-residue sequence. Six interdomain insertions (desig-
nated IS1–IS6) separate the five Ig repeats. To search for
proteins homologous to myopalladin, a BLAST search was
performed with its 145-kD peptide sequence (BLAST2
from the National Center for Biotechnology Information
server). From known proteins, Ig repeats from palladin
(human: EMBL/GenBank/DDBJ under accession num-
ber AB023209; mouse: Parast and Otey, 2000) (68% iden-
tity), the Z-disc protein myotilin (Salmikangas et al., 1999)
(50% identity), and titin’s central I-band N2B region (48%
identity) were most related to myopalladin (Fig. 2 C). The
two NH2-terminal Ig domains in myopalladin are most ho-
mologous to Ig domains from the N2B region of titin in the
I-band region. Myopalladin’s three COOH-terminal Ig do-
mains are most related to palladin’s Ig domains, whereas
the two most COOH-terminal Ig domains also share high
homology to myotilin’s Ig domains (Fig. 2 D).
Figure 1. Yeast two-hybrid screens identify myo-
palladin and desmin as Z-line nebulin-binding
proteins. Schematic structure of the COOH-ter-
minal region of nebulin and its location within the
sarcomere is shown based on previous immuno-
electron microscopy studies (Millevoi et al., 1998).
The nebulin COOH-terminal region constructs
pAS2-M160-M1851Ser1SH3C and pAS2-M160-
M183 identified myopalladin and desmin prey
clones in yeast two-hybrid screens. Nebulin bait
deletion constructs (NebD1–NebD3) allowed us to
further map the myopalladin-binding region on
nebulin to within the nebulin SH3 domain. The
desmin-binding site on nebulin was found to be
located within the nebulin M160-M183 modules.
(1) and (2) denote the presence or absence of
the growth of yeast colonies on SD/Trp-/Leu-/
His-plates supplemented with 1.5 mM 3-AT.Bang et al. Myopalladin Assemblies 417
The sequence homology of myopalladin to the recently
described 90–92-kD palladin protein from mouse is most
significant, because palladin’s entire sequence, including
its COOH-terminal three Ig repeats and its unique NH2-
terminal domain, is colinear with and conserved to myo-
palladin’s COOH-terminal 92 kD (Fig. 2 B). In particular,
the COOH-terminal part of palladin containing three Ig
domains is 63% identical to myopalladin’s COOH-termi-
nal region (Fig. 2, A and B). Also highly conserved to pal-
ladin is a 15-residue box in myopalladin (residues 643–658;
Fig. 2 B), which corresponds to myopalladin’s SH3-bind-
ing site (see below). Palladin’s PPPPP domains and Ser-
rich domains, noted by Parast and Otey (2000), are not
found in myopalladin (corresponding to gaps in Fig. 2 B).
By searching the human genome database with myopalla-
din and palladin cDNAs, the myopalladin gene was shown
to be derived from a single locus, located on chromosome
10q21.1 between the markers D10S207 and D10S561. Palla-
Figure 2. Myopalladin is a novel 145-kD protein
with homology to palladin. (A) Comparison of the
domain architecture of myopalladin and the re-
cently described palladin protein (Parast and Otey,
2000). The Ig-I repeats are shown in gray, the
unique sequences are shown in white, and the pro-
line-rich PPP motif regions are shown in black. The
bars above the myopalladin and below the palladin
schematics indicate the recombinant fragments of
the proteins that were used as antigens to generate
specific antibodies (see Fig. 7 for the characteriza-
tion of the antibodies). (B) Dot plot matrix se-
quence comparison of myopalladin and palladin.
The regions of myopalladin and palladin that bind
to the nebulin SH3 domain and to a-actinin are the
most conserved regions between the two proteins.
(C) Peptide sequence alignment of myopalladin’s
five Ig-I domains and comparison with Ig-I do-
mains from myotilin (EMBL/GenBank/DDBJ ac-
cession number AF144477), titin N2B (accession
number X90568), and palladin (accession number
AB023209). All sequences are from humans. Iden-
tical residues are indicated by asterisks. (D) Phylo-
genetic tree based on the comparison of myopalla-
din’s Ig-I repeats and the most related Ig-I repeats
from myotilin, titin, and palladin.The Journal of Cell Biology, Volume 153, 2001 418
din was mapped to a single locus on chromosome 4q31.3 be-
tween the markers D4S1596 and D4S2910. To determine
the expression pattern of the myopalladin gene, a specific
probe corresponding to its full-length cDNA sequence was
hybridized to a multiple tissue RNA blot. Myopalladin gene
expression was found to be restricted in adult to striated
muscle tissues (Fig. 3). Consistent with the results of Parast
and Otey (2000), the palladin gene was found to be ubiqui-
tously expressed in all tested tissues. The highest levels of
palladin expression were noted in cardiac muscle and in tis-
sues with a high content of smooth muscle (Fig. 3).
In conclusion, myopalladin and palladin are members of
the same gene family which have conserved COOH-termi-
nal and SH3-binding domains. Palladin is encoded by a
gene located on chromosome 4q31.3 and is ubiquitously
expressed, whereas the myopalladin gene on chromosome
10q21.1 encodes a 145-kD protein, whose expression is re-
stricted to striated muscle tissues (explaining the name
given to this protein).
Myopalladin’s Central IS3 Domain Interacts with 
Nebulin and Nebulette’s SH3 Domain
To identify more precisely the sequences responsible for
the nebulin–myopalladin interaction, nebulin and myo-
palladin subfragments were cotransformed into yeast
(Figs. 1 and 4 A). Since the nebulin bait, pAS2-M160-
M1851Ser1SH3, was partly autoactivating, nebulin trun-
cations were made in the prey vector and myopalladin
truncations in the bait vector. Truncations of pAS2-M160-
M1851Ser1SH3 indicated that nebulin’s SH3 domain
alone is sufficient for the interaction with myopalladin
(Fig. 1). The additional presence of the Ser-rich domain,
however, further enhanced yeast growth and b-galacto-
sidase activity and may therefore be responsible for
strengthening the interaction (Fig. 1).
Truncation analysis of myopalladin indicated that a 42-
residue proline-rich stretch within IS3 is sufficient for the
interaction with nebulin’s SH3 domain (Fig. 4 A). Binding
sites for SH3 domains are typically proline-rich stretches
of z10 amino acids, which are capable of adopting a
polyproline II helix conformation (Musacchio et al., 1992).
Within myopalladin’s IS3 domain, three such proline-rich
motifs are present. To determine if these motifs are re-
sponsible for SH3-binding, pairs of proline residues in
myopalladin-D2 (Fig. 4 A), within three predicted poten-
tial SH3-binding motifs, were mutated to glycines (myo-
palladin-D2-mut1,2,3; Fig. 4 B). Cotransformation of
myopalladin-D2-mut3 with nebulin indicated that myopal-
ladin’s proline residue triplet (PPP), residues 649–651, are
required for binding, since this mutation abolished the in-
teraction. The other two mutants, myopalladin-D2-mut1,2
(residues 573–576 and 642–645) did not affect nebulin
binding (Fig. 4 D). The interaction of nebulin M1841
Ser1SH3 and myopalladin-D2/myopalladin-D2-mut3 fu-
sion peptides was also tested by GST pull-down assays.
Nebulin’s COOH-terminal region coprecipitated with the
wild-type GST–myopalladin-D2 but not with GST alone
and only weakly with the GST–myopalladin-D2-mut3 pep-
tide (Fig. 4 C). This confirmed that the nebulin SH3 do-
main specifically binds to myopalladin, involving the PPP
motif, residues 649–651, which is located within myopalla-
din’s central IS3 domain (Fig. 4 A).
Figure 3. Northern blot analysis reveals that detectable myopalladin gene expression
is restricted to striated muscle. Myopalladin- and palladin-specific cDNA probes were
hybridized to human RNA master blots (CLONTECH Laboratories, Inc.). Left, myo-
palladin gene expression is restricted to skeletal muscle (C3), fetal heart (G2), and
adult heart (C1). Right, palladin transcripts are detected in all human tissues tested
and are particularly abundant in striated and smooth muscle tissues (e.g., bladder,
uterus, prostate, and stomach, C5–C8, respectively).Bang et al. Myopalladin Assemblies 419
Figure 4. Yeast two-hybrid screens reveal that myopalladin’s nebulin-binding and a-actinin–binding sites are located in two distinct
domains within its COOH-terminal 90-kD region. (A) Schematic structure of human full-length myopalladin cDNA. Numbers indi-
cate nucleotide residue numbers (top, labeled bp) and amino acid residue numbers (below the nucleotide number, labeled aa). AAA
indicates a poly(A1) tail. The Ig domains are shown in gray and are numbered I–V. Unique sequences are labeled IS1–6. Lines above
the myopalladin domain structure indicate the myopalladin regions that were expressed as GFP fusion proteins in live cardiac myo-
cytes (full-length myopalladin, two NH2-terminal fragments, one COOH-terminal fragment, and one internal fragment). Lines below
indicate the partial myopalladin bait constructs that were generated for yeast two-hybrid screens to test for binding to the nebulin
SH3 domain, a-actinin, and CARP. (1) and (2) denote the presence or absence of the growth of yeast colonies on SD/Trp-/Leu-/
His-plates supplemented with 1.5 mM 3-AT. Myopalladin’s nebulin-binding region was mapped to a part of IS3, whereas myopalla-
din’s a-actinin–binding site was mapped to its COOH-terminal 375 residues. The CARP-binding site was assigned to myopalladin’s
NH2-terminal 522 residues. (B) The IS3 sequence of myopalladin contains three proline residue–rich motifs (labeled 1, 2, and 3). In
each motif, pairs of proline residues (arrows) were mutated pairwise to glycine residues to obtain the bait constructs myopalladin-
D2-mut1, 2, and 3. (C) Myopalladin interacted with nebulin in GST pull-down assays. In vitro–translated Ser1SH3 nebulin fragment
(IVT-nebulin, lane 1) bound to glutathione-Sepharose 4B beads in the presence of GST-myopal-D2 wild-type (wt) fusion peptide
(lane 3); a weaker binding was observed when proline residues 649 and 651 were mutated (lane 4; GST-myopal-D2-mut3 in B). As a
negative control, binding of GST and nebulin Ser1SH3 to beads was tested (lane 2). (D) Interaction of myopalladin and nebulin/
nebulette in the yeast two-hybrid system. Partial myopalladin cDNAs were cotransformed with partial nebulin/nebulette cDNAs
into S. cerevisiae (see Fig. 3 A). The partial myopalladin sequence, myopalladin-D5 (IS3), was sufficient for binding to the SH3 do-
main of nebulin (Neb-D2). The myopalladin-D2-mut1,2 bait, but not the myopalladin-D2-mut3 bait interacted with nebulin preys, in-
dicating that the PPP motif in myopalladin (residues 649–651) is involved in the interaction with nebulin. Additionally, myopalladin
also bound to the SH3 domain of nebulette.The Journal of Cell Biology, Volume 153, 2001 420
Finally, as nebulette is thought to be a functional homo-
logue of the Z-disc part of nebulin in the heart (Moncman
and Wang, 1995; Millevoi et al., 1998), the Ser1SH3 do-
mains of nebulette from human heart were cotransformed
with myopalladin-D2. This experiment demonstrated that
the SH3 domain of nebulette also interacts with myopalla-
din (Fig. 4 D). Therefore, both the SH3 domains of skele-
tal muscle nebulin and cardiac muscle nebulette specifi-
cally interact with myopalladin.
Myopalladin’s COOH-terminal Region Interacts with 
the COOH-terminal, EF Hand Region of a-Actinin
To search for other myopalladin binding partners, we
screened a human skeletal muscle cDNA library with a
bait containing myopalladin’s full-length coding sequence
(BTM-myopalladin; Fig. 4 A). By screening of z1.2 3 106
colonies, 700 prey clones were identified, all of which were
confirmed in the b-galactosidase assay. 65 b-galactosi-
dase–expressing clones were randomly chosen and se-
quenced. Three of the prey clones were derived from the
COOH-terminal part of nebulin, confirming again the
nebulin SH3–myopalladin interaction. 13 of the prey
clones contained parts of the ACTN2 gene, which encodes
the a–actinin-2 isoform (Beggs et al., 1992). When hybrid-
izing a–actinin-2 probes to the 700 yeast colonies from
the myopalladin screen, 155 clones (22%) hybridized to
ACTN2. Sequence analysis of 12 ACTN2-positive clones
showed that they all share a region of overlap in the
COOH-terminal region of sarcomeric a–actinin-2. To fur-
ther narrow down the myopalladin-binding site within
a–actinin-2, the interaction of myopalladin with various
deletion constructs of a–actinin-2 (Sorimachi et al., 1997)
was tested (Fig. 5 A). This analysis showed that a-actinin’s
binding site for myopalladin is located in the COOH-ter-
minal part of a–actinin-2, from just after the spectrin re-
peats (before the two EF hands) up to the extreme COOH
terminus. This interaction was confirmed by GST pull-
down assays (Fig. 5 B).
Our two-hybrid screens isolated only a–actinin-2 iso-
forms. To test if the interaction with myopalladin was spe-
cific to the a–actinin-2 isoform, we also tested a–actinin-3
prey constructs, encoding a skeletal muscle–specific isoform
of a-actinin (Beggs et al., 1992). This showed that a–actinin-3
also interacted with myopalladin (data not shown).
To determine the sequences in myopalladin that are re-
quired for binding to a-actinin, truncated myopalladin
constructs were tested (Fig. 4 A). Using this approach,
myopalladin’s a-actinin–binding site was assigned to the
COOH-terminal region of myopalladin. The results indi-
cated that all three Ig domains, III1IV1V within the
COOH-terminal region of myopalladin, are required for
binding to a–actinin-2. We conclude that myopalladin’s
COOH-terminal 43 kD and a-actinin’s COOH-terminal
EF hand region specifically interact.
Myopalladin’s NH2-terminal Domain Interacts with 
Sarcomeric CARP
To search for proteins interacting with myopalladin’s
NH2-terminal domain, the NH2-terminal 1,605 kb was
cloned into the yeast two-hybrid bait vector BTM117c and
used to screen a human skeletal muscle cDNA library. By
screening of z900,000 clones, 100 clones were identified.
88 were confirmed in the b-galactosidase assay, and 20
were analyzed by sequencing. Six of the sequenced clones
encoded the cardiac ankyrin repeat protein, CARP (Chu
et al., 1995). All six CARP clones corresponded to full-
length cDNAs. Also, when 59 and 39 deletions were intro-
duced into CARP, the interaction with myopalladin’s
NH2-terminal domain was ablated, suggesting that a full-
length version of CARP is required for its interaction with
myopalladin (data not shown). The specific interaction
of myopalladin’s NH2-terminal region with a full-length
CARP protein was confirmed by GST pull-down experi-
ments (Fig. 6 A).
Endogenous CARP has been detected previously in the
nucleus and no sarcomeric forms have been reported (e.g.,
Zou et al., 1997). Therefore, to test if endogenous CARP
is indeed present in the sarcomere, a novel antibody was
raised to an NH2-terminal subfragment of CARP that ap-
pears to be specific for CARP. On Western blots, this anti-
body recognized a single 40-kD band which corresponded
to the previously reported (Jeyaseelan et al., 1997; Zou et
Figure 5. Myopalladin interacts with the EF hand region
of a–actinin-2. (A) The schematic structure of a–acti-
nin-2 (ACTN2) with its four central rod domains, R1–R4,
and its unique terminal sequence is shown. Numbers in-
dicate the nucleotide or amino acid residue numbers de-
duced from the human full-length cDNA sequence.
AAA indicates a poly(A1) tail. A series of ACTN2 dele-
tion constructs (below) were tested for interaction with
full-length myopalladin in the yeast two-hybrid system.
This assigned the myopalladin-binding domain within
a-actinin to its COOH-terminal region containing the
two EF hands. (1) and (2) denote the presence or ab-
sence of the growth of yeast colonies on SD-/Trp-/Leu-/
His-plates supplemented with 1.5 mM 3-AT. (B) Interac-
tion of myopalladin with a-actinin in GST pull-down as-
says. Myopalladin’s COOH-terminal 376 residues were
translated in vitro (IVT-myopal-D6, left). When incu-
bated together with expressed ACTN14-GST fusion pep-
tides, their binding to glutathione-Sepharose 4B beads
was observed (right). Middle lane, negative control pull-
down performed without the addition of the a-actinin
fragment (for details, see Materials and Methods).Bang et al. Myopalladin Assemblies 421
al., 1997) molecular mass of CARP protein (Fig. 6 B). To
ascertain the cellular localization of CARP in striated
muscle, we stained isolated myofibrils from rat heart and
skeletal muscle, as well as isolated rat cardiac myocytes
with our anti-CARP–specific antibody. Consistent with
earlier data on the nuclear targeting of CARP, endoge-
nous CARP was detected within the nucleus of rat cardiac
myocytes (Fig. 6 C, c9; CARP staining in green, myomesin
staining in red). However, endogenous CARP protein was
also detected in a striated pattern in both isolated myo-
fibrils and in cardiac myocytes, indicating that CARP is a
myofibrillar component. Costaining with a marker of the
M-line, the myosin-associated protein, myomesin, re-
vealed that CARP is distributed in the I-band, as a doublet
in close proximity to the Z-line in both heart and skeletal
muscle (Fig. 6 C, a9 and b9, myomesin staining not shown).
Notably, CARP was not detected in I-Z-I (i.e., precursor
Z-line/stress-fiber–like) structures at the edges of cardiac
myocytes in culture (Fig. 6 C, c9, arrowheads). To deter-
mine more precisely the localization of sarcomeric CARP,
immunoelectron microscopy was performed on mouse
cardiac myofibrils. This experiment confirmed that a
CARP protein is present in the central I-band region of
the sarcomere (Fig. 6 D).
Localization and Assembly of Myopalladin and Palladin 
in Striated Muscle
To study the endogenous localization of myopalladin and
palladin, specific antibodies to expressed myopalladin and
palladin fragments were raised (Fig. 2 A). Western blot
analysis of different tissues using our affinity-purified anti-
myopalladin-1 antibodies detected a single band of z155
kD in rabbit cardiac, soleus, and psoas skeletal muscle (Fig.
7 A). This slightly slower mobility of myopalladin observed
on gels than expected from its predicted molecular mass
raises the possibility of posttranslational modifications (e.g.,
differential phosphorylation). For palladin, a single, promi-
nent band at z92 kD was detected with our polyclonal anti-
palladin antibodies in smooth muscle (Parast and Otey,
2000), whereas bands at z90–92 and z60 kD in heart, as
well as a band at z55 kD in skeletal muscle, were observed
(Fig. 7 B). With longer exposure times, reactivity to a faint
band at z155 kD was also detected in cardiac and skeletal
muscle. This could result from the cross-reactivity of our
polyclonal antipalladin antibodies with the homologous
myopalladin protein. However, since the palladin antibod-
ies were raised to a region which is not homologous to myo-
palladin, it is not likely that the antipalladin antibodies
cross-react with myopalladin. Additionally, by immunofluo-
Figure 6. Identification of CARP as a sarcomeric
component. (A) Interaction of myopalladin with
CARP in GST pull-down assays. Full-length
CARP was translated in vitro (left). When incu-
bated together with GST-myopalladin fusion pep-
tide (fragment myopal-N; see Fig. 4 A), binding to
glutathione-Sepharose 4B beads was observed
(right). Middle lane, negative control pull-down
performed with GST and CARP peptides. (B)
Specificity of affinity-purified anti-CARP antibod-
ies. Western blot analyses of rat heart muscle ly-
sates reveal that polyclonal antibodies raised to
CARP react with a single 40-kD band (lane 2). No
bands are detected in the control lane, which was
incubated with secondary antibody alone (lane 1).
(C) Immunofluorescence staining of CARP in
washed isolated myofibrils from rat heart (a9) and
skeletal (b9) muscle, as well as in primary cultures
of rat cardiac myocytes (c9; CARP staining in
green, myomesin staining in red), demonstrating
that CARP is a sarcomeric component. Isolated
myofibrils and cardiac myocytes were labeled with
affinity-purified anti-CARP antibodies, followed
by Cy2-conjugated secondary antibodies, and with
antimyomesin antibodies (data not shown in a9
and b9) followed by Texas red–conjugated second-
ary antibodies. The merged images revealed that
CARP is localized as a doublet within the I-band
(in close proximity to the Z-line) in both heart and
skeletal myofibrils and in isolated cardiac myo-
cytes. Double arrows in a9 and b9 mark I-band
staining. Arrowheads (in c9) indicate the absence
of detectable CARP (and myomesin) staining in
I-Z-I bodies, located at the edges of cultured car-
diac myocytes. Note the additional staining of
CARP in the nucleus in c9. N, nucleus. (D) Immu-
noelectron microscopy with CARP-specific anti-
bodies demonstrates that CARP is present in the
central I-band in cardiac myofibrils from mouse left
ventricle. Z, Z-disc. Bars: (C) 10 mm; (D) 250 nm.The Journal of Cell Biology, Volume 153, 2001 422
rescence staining the antimyopalladin and antipalladin anti-
bodies appear not to cross-react, since both antibodies dem-
onstrated differences in their staining patterns (Fig. 7). The
results from our Western blot analysis are consistent with
those reported in adult tissues using monoclonal antipalla-
din antibodies in Parast and Otey (2000), with the exception
that our polyclonal antipalladin antibodies appeared to rec-
ognize more palladin-related proteins (although the smaller
proteins we detected may not have been resolved on their
gel system).
To ascertain the cellular localization of myopalladin in
striated muscle, we performed immunofluorescence stain-
ing with our antimyopalladin-1–specific antibodies on iso-
lated rat heart and skeletal myofibrils. Costaining with a
marker of the M-line, the myosin-associated protein myo-
mesin, revealed that myopalladin is localized at the Z-line
region in both heart and skeletal myofibrils (Fig. 7 C, a9
and c9); however, in some sarcomeres, a doublet of myo-
palladin staining is detected, indicating that this protein is
also localized within the I-band (Fig. 7 C, b9 and d9; stain-
ing with myomesin not shown). In isolated rat cardiac
myocytes, myopalladin is also detected (with varying in-
tensities) within the nucleus of z75% cells (Fig. 7 C, e9;
myopalladin staining in green, myomesin staining in red).
Figure 7. Characterization of
endogenous myopalladins
and palladins in striated mus-
cle. (A) Specificity of affin-
ity-purified antimyopalladin
antibodies. Antimyopalladin
antibodies recognize a band
at z155 kD in rabbit heart
(lane 1), soleus (lane 2), and
psoas muscle (lane 3) by
Western blot analysis. Note,
on some blots an z35-kD
band was also detected; the
detection of this band was
variable and its significance
is unknown. (B) Specificity
of affinity-purified antipalla-
din antibodies. Antipalladin
antibodies recognize a 92-kD
band in rat smooth muscle
from the small intestine (lane
3), as well as multiple bands
in heart (lane 1) and skeletal
muscle (lane 2). (C) Immu-
nofluorescence staining of
myopalladin in washed, iso-
lated myofibrils from rat
heart (a9 and b9) and skeletal
(c9 and d9) muscle, as well as
in primary cultures of rat car-
diac myocytes (e9; myopal-
ladin staining in green,
myomesin staining in red)
demonstrating that myopal-
ladin can be detected as a
single striation at the Z-line
(a9 and c9, arrows) and as a
doublet within the I-band (in
close proximity to the Z-line)
(b9 and d9, double arrows). Isolated myofibrils and cardiac myocytes were labeled with affinity-purified antimyopalladin-1 antibodies,
followed by Cy2-conjugated secondary antibodies, and with antimyomesin antibodies (data not shown in a9–d9) followed by Texas red–
conjugated secondary antibodies. Note the additional staining of myopalladin in the nucleus in e9. Arrowheads in e9 mark the absence
of detectable myopalladin (and myomesin) staining in I-Z-I bodies, located at the edges of cultured cardiac myocytes. (f9) Immunofluo-
rescence image demonstrating the targeting of expressed GFP-myopalladin to the Z-line and to the I-band in primary cultures of chick
cardiac myocytes. Cardiomyocytes expressing GFP–full-length myopalladin were fixed 3–5 d after transfection and stained with anti-
myomesin antibodies followed by Texas red–conjugated secondary antibodies and analyzed by immunofluorescence microscopy. Single
arrows mark Z-line staining, whereas double arrows mark I-band staining. Significant variability in the relative labeling intensities of
myopalladin at the Z-line vs. the I-band was observed. N, nucleus. (D) Immunofluorescence staining of palladin in washed, isolated myo-
fibrils from rat heart (a9) and skeletal (b9) muscle, as well as in primary cultures of rat cardiac myocytes (c9; palladin staining in green,
myomesin staining in red), demonstrating that palladin is localized at the Z-line. Isolated myofibrils and cardiac myocytes were labeled
with affinity-purified antipalladin antibodies, followed by Cy2-conjugated secondary antibodies, and with antimyomesin antibodies
(data not shown in a9 and b9) followed by Texas red–conjugated secondary antibodies. Arrowheads in c9 mark the presence of palladin
(but not myomesin) staining in I-Z-I bodies, located at the edges of cultured cardiac myocytes. Note that palladin staining was not de-
tected in the nucleus in c9. N, nucleus. Bars, 10 mm.Bang et al. Myopalladin Assemblies 423
Palladin was also detected at the Z-line (but not within the
I-band) in isolated rat heart and skeletal myofibrils (Fig. 7
D, a9 and b9; staining for myomesin not shown). No stain-
ing for palladin was detected in the nucleus in rat cardiac
myocytes (Fig. 7 C, c9; palladin staining in green, myo-
mesin in red). Furthermore, palladin (Fig. 7 D, c9) but not
myopalladin (Fig. 7 C, c9) was detected in I-Z-I bodies at
the edges of the cardiac myocytes.
To determine the cellular localization of myopalladin
when being expressed in primary cultures of chick cardiac
myocytes, we transfected cells with a GFP fusion construct
encoding full-length myopalladin. Full-length GFP-myo-
palladin was mainly targeted to Z-lines (single band in
green), with some targeting to I-bands (double band in
green), as demonstrated by costaining for myomesin
(shown in red) (Fig. 7 C, f9).
Consistent with the immunofluorescence data, immuno-
electron microscopy studies with myopalladin-specific an-
tibodies detected myopalladin both within the periphery
of the Z-line (Fig. 8 A) and in the central I-band (Fig. 8,
A–C). In fact, measurements of the CARP and myopalla-
din epitopes from the Z-disc revealed that the two pro-
teins colocalized within the central I-band (Fig. 8 D).
Interestingly, for both I-band–bound myopalladin and
Figure 8. Immunoelectron microscopy reveals
colocalization of myopalladin and CARP in
mouse cardiac myofibrils. (A–C) Isolated myo-
fibrils from mouse were prepared and stretched
according to Trombitás et al. (1995); immuno-
electron microscopy with affinity-purified anti-
myopalladin antibodies reveals that myopalladin
is detected both within the periphery of the
Z-line (A) and in the central I-band region
(A–C). In stretched sarcomeres (B), the Z-line
to I-band distance increases. A, unstretched; B,
slightly stretched; C, high magnification view of
Z-disc in stretched myofibrils. (D) The distances
of I-band–bound CARP and myopalladin from
the Z-disk were measured from immunoelectron
micrographs at different sarcomere lengths (29
micrographs were analyzed for CARP; 54 micro-
graphs for myopalladin). Both CARP and
myopalladin colocalize in the central I-band and
their epitope distances (in mm) from the Z-disc
were dependent on sarcomeric length (SL).The Journal of Cell Biology, Volume 153, 2001 424
CARP the distances of their epitopes from the Z-line were
dependent on stretch (i.e., sarcomere length). In contrast,
the Z-line–bound myopalladin remained in a fixed posi-
tion. This raises the possibility that CARP and the I-band–
bound myopalladin are attached to the elastic titin filament,
whereas the Z-line–bound myopalladin is an integral com-
ponent within Z-lines.
Effects of Overexpression of Myopalladin on
Z-Line Integrity
To investigate the functional significance of the individual
domains of myopalladin in Z-line organization, we trans-
fected chick cardiac myocytes with constructs encoding
GFP fusions with full-length myopalladin, as well as four
myopalladin subfragments (Fig. 4 A). Two fragments cor-
responded to myopalladin’s NH2-terminal CARP-binding
region, one to its middle nebulette/nebulin-binding region,
and one to its COOH-terminal a-actinin–binding region.
We observed the effects of overexpressing these domains
on the organization of a-actinin, a marker for Z-line struc-
ture, using immunofluorescence microscopy (Fig. 9). Con-
trol cells expressing GFP alone exhibited a diffuse staining
pattern for GFP (Fig. 9 a) with mature, repeating a-actinin
staining (Fig. 9 b). When full-length GFP-myopalladin was
overexpressed in cells, it mainly assembled in a striated
pattern at the Z-line (Fig. 9 c), colocalizing with a-actinin,
which was assembled in a mature striated pattern (Fig. 9
d), whereas some assembled at the I-band (Fig. 7 C, f9). In
cells overexpressing either the middle region (Fig. 9 i) or
the COOH-terminal region (Fig. 9 k) of myopalladin, no
perturbation of Z-line structure was observed (Fig. 9, j and
l, respectively). In contrast, in cells overexpressing either
of two myopalladin NH2-terminal domain GFP fusion pro-
teins (Fig. 9, e and g), an extensively disrupted Z-line
structure (i.e., a-actinin staining) in 80–85% of all trans-
fected myocytes was observed (Fig. 9, f and h).
Effects of Overexpression of Myopalladin on
Sarcomeric Integrity
Since the Z-lines of cells overexpressing the NH2-terminal
region of myopalladin were disrupted, we next investi-
gated the effects of overexpressing this region on overall
sarcomeric integrity by observing effects on the thin, thick,
and titin filament systems. Thin filament integrity was ex-
amined by staining transfected cells for actin using Texas
red–labeled phalloidin, whereas thick filament organiza-
tion was investigated using two markers, antimyosin and
antimyomesin antibodies. Antibodies specific for a region
close to the NH2-terminal (Z-line) region of titin (T11)
and the COOH-terminal M-line region of titin (T114)
were used to analyze the effects of the overexpression of
the NH2-terminal region of myopalladin on the titin third
filament system. In cells expressing GFP alone (Fig. 10, a,
g, and m), actin filaments (Fig. 10 b), titin T11 (Fig. 10 h),
titin T114 (data not shown), myomesin (Fig. 10 n), and my-
osin (data not shown) appeared in their respective typical
striated pattern. Additionally, myocytes overexpressing
full-length GFP-myopalladin demonstrated a striated pat-
tern (Fig. 10, c, i, and o) and typically assembled actin (Fig.
10 d), titin T11 (Fig. 10 j), titin T114 (data not shown), myo-
mesin (Fig. 10 r), and myosin (data not shown). In con-
trast, myocytes overexpressing the GFP–NH2-terminal re-
gion of myopalladin (Fig. 10, e, k, and q), exhibited a
dramatic sarcomeric disruption, owing to the disrupted
thin (Fig. 10 f), titin (Fig. 10 l), and thick (Fig. 10 p) fila-
ment systems in 80–85% of transfected cells. Similar re-
sults were obtained in myocytes overexpressing GFP–
myopalladin-IS1, a smaller fragment of the NH2-terminal
region of myopalladin that also contains the CARP-bind-
ing site (data not shown). The most likely explanation for
this phenomenon is that a dominant negative phenotype
occurred. That is, overexpression of the NH2-terminal re-
gion of myopalladin competed for the CARP-binding site
Figure 9. Overexpression of
the NH2-terminal region of
myopalladin in cardiac myo-
cytes results in marked dis-
ruption of Z-line archi-
tecture as indicated by
a-actinin staining. Cardiac
myocytes expressing GFP
alone (GFP; a), GFP–full-
length myopalladin (GFP-
myopalladin; c), GFP-
myopalladin NH2-terminal
region (GFP–myopal-N; e),
a smaller GFP–NH2-termi-
nal myopalladin IS1 region
(GFP–myopal-IS1; g), GFP-
myopalladin central region
(GFP–myopal-Cen; i), and
GFP-myopalladin COOH-
terminal region (GFP–myo-
pal-C; k) were fixed 3–5 d
after transfection and stained with anti–a-actinin antibodies followed by Texas red–conjugated secondary antibodies (b, d, f, h, j, and
l). Arrows point to the typical striated staining pattern of a-actinin in transfected cardiac myocytes (b, d, j, and l); arrowheads point
to disrupted a-actinin staining pattern in transfected myocytes (f and h). Bar, 10 mm.Bang et al. Myopalladin Assemblies 425
on endogenous myopalladin. These data indicate a critical
role for the NH2 terminus of myopalladin containing the
CARP-binding domain for sarcomeric structure.
Discussion
In this study, we aimed to further dissect the molecular
components required for the coordinated organization of
Z-line components into regular, hexagonal lattices. We
took the approach of searching for protein interactions
that anchor the COOH-terminal region of nebulin within
the sarcomere. This allowed us to identify the specific
binding of the nebulin modules M160–M183, from the pe-
ripheral (I-band side) region of the Z-line (Millevoi et al.,
1998), with the intermediate filament protein, desmin.
Studies are currently under investigation to determine
whether desmin and nebulin indeed participate in a coordi-
nated cytoskeletal network that could provide lateral link-
ages in the Z-line perimyofibrillar space, allowing for effi-
cient force transmission and mechanochemical signaling.
This study has also led to the identification of a novel
nebulin-binding protein, myopalladin, which we named
based on its striking homology with the recently described
ubiquitously expressed protein, palladin (Parast and Otey,
2000). The homology of palladin and myopalladin suggests
that they are members of the same gene family. Palladin
colocalizes with a-actinin in focal adhesions, stress fibers,
cell–cell junctions, and Z-lines, and is critical for the orga-
nization of the actin cytoskeleton and focal adhesions
(Parast and Otey, 2000). The 63% sequence identity of
myopalladin to palladin within its a-actinin–binding re-
gions raises the intriguing possibility that the assembly of
nonmuscle stress fibers and sarcomeres share common reg-
ulatory mechanisms involving myopalladin and palladin.
Previous studies have demonstrated that both the nebu-
lette and nebulin SH3 domains target to vertebrate Z-lines
Figure 10. Overexpression of the NH2-terminal region of myopalladin in car-
diac myocytes results in disruption of thin, titin, and thick filaments. Chick car-
diac myocytes expressing GFP alone (GFP; a, g, and m), GFP–full-length myo-
palladin (GFP-myopalladin; c, i, and o), and GFP–NH2-terminal myopalladin
region (GFP–myopalladin-N; e, k and p) were fixed 3–5 d after transfection and
stained with Texas red–conjugated phalloidin (b, d, and f), antititin T11 antibod-
ies followed by Texas red–conjugated secondary antibodies (h, j, and l), or anti-
myomesin antibodies followed by Texas red–conjugated secondary antibodies
(n, p, and r). Arrows point to typical striated staining pattern of actin (b and d),
titin (h and j), and myomesin (n and p); arrowheads point to disrupted actin (f),
titin (l), and myomesin (r). Bar, 10 mm.The Journal of Cell Biology, Volume 153, 2001 426
when expressed in avian cardiac and skeletal myocytes, re-
spectively (Moncman and Wang, 1999; Ojima et al., 2000).
However, the molecular basis that allows for the targeting
of the SH3 domain to Z-lines has been unclear; that is,
could a direct interaction of nebulin/nebulette with a-acti-
nin account for the targeting of the nebulin/nebulette SH3
fragments to the Z-line (Nave et al., 1990; Moncman and
Wang, 1999)? Based on our immunoelectron microscopy
(this report and Millevoi et al., 1998), cellular targeting, and
biochemical studies, we predict that the proline residue–rich
motif (the triple proline PPP motif, residues 649–651) in the
central IS3 domain of myopalladin interacts with the SH3
domains of nebulin and nebulette, thereby anchoring them
z25 nm inside the Z-line. Also, myopalladin’s PPP motif,
and its flanking residues, are highly conserved in palladin
(Fig. 2 B). This strongly suggests that palladin’s PPP motif
can also interact with the SH3 domains of nebulin and neb-
ulette in skeletal and cardiac muscle, respectively.
Myopalladin’s COOH-terminal region, in turn, specifi-
cally binds to the EF hand motifs of a-actinin. By extrapo-
lating our data on the properties of myopalladin to what is
known about palladin, we would predict that palladin’s
COOH-terminal three Ig domains interact with a-actinin
in muscle Z-lines and in nonmuscle cells. Therefore, the
data presented here, together with previous reports dem-
onstrating the association of a-actinin with titin Z-repeats
(Ohtsuka et al., 1997; Sorimachi et al., 1997; Gregorio et
al., 1998; Young et al., 1998), predict that palladin/myopal-
ladin and a-actinin may form a linking system, tethering
the barbed ends of the actin-thin filaments, the NH2-termi-
nal ends of titin filaments, and the COOH-terminal ends
of nebulin filaments (skeletal muscle) and nebulette (car-
diac muscle) within the Z-line. Therefore, we speculate
that the palladin/myopalladin–a-actinin complexes are
major players in assembling I-Z-I bodies in striated muscle
(Epstein and Fischman, 1991; Holtzer et al., 1997; Ehler et
al., 1999; Ojima et al., 1999; Gregorio and Antin, 2000).
The palladin/myopalladin–a-actinin interaction could pro-
vide the anchor to stabilize these structures during devel-
opment, similar to palladin’s proposed role in stabilizing
stress fibers in nonmuscle cells (Parast and Otey, 2000). It
will be interesting to see if the PPP motif from nonmuscle
palladin also interacts with other SH3 domain–containing
proteins in nonmuscle cells, which are involved in regula-
tion of stress fiber assembly.
Although myopalladin and palladin are highly homolo-
gous and are coexpressed and localized in Z-lines in ma-
ture sarcomeres (Fig. 7), these two molecules appear to
have very different cellular properties. Palladin, but not
myopalladin, is detected in the earliest I-Z-I bodies, struc-
tures which are precursor Z-lines (for cardiac myocytes,
Fig. 7; for myopalladin in skeletal myogenic cells, Holtzer,
H., personal communication). Possibly during myofibril
assembly, some palladin complexes can be replaced by
myopalladin Z-line complexes. Furthermore, myopalladin,
in contrast to palladin, also localizes to the I-band and in-
teracts with CARP (Figs. 4 and 7). Also, the myopalladin
NH2-terminal domain is rich in potential phosphorylation
sites and is efficiently phosphorylated by muscle extracts
(data not shown), whereas palladin is missing these sites.
Finally, palladin is extensively differentially spliced, ac-
counting for the multiple bands detected on Western blots
(this study and Parast and Otey, 2000). In contrast, blots
probed for myopalladin did not display multiple bands
(Fig. 7). Interestingly, we identified a specific splice iso-
form of palladin that is missing the exon encoding the
COOH-terminal Ig repeat that is predicted to be involved
in binding to a-actinin (data not shown). In summary, it
appears that although myopalladin and palladin may inter-
act with SH3 domain–containing proteins via their con-
served binding sites, the two proteins are likely to be regu-
lated by different mechanisms. A molecular understanding
of how the palladin/myopalladin–a-actinin complex as-
sembly is regulated is likely to improve our general under-
standing of Z-line assembly and maintenance.
Finally, myopalladin’s NH2-terminal domain binds
CARP. The CARP protein contains a nuclear localization
signal, has been reported to be exclusively localized in the
nucleus, and has been shown to negatively regulate the ex-
pression of cardiac genes, including the ventricular-spe-
cific myosin light chain-2, natriuretic factor, and cardiac
troponin-C genes (Jeyaseelan et al., 1997; Zou et al.,
1997). CARP is expressed abundantly and specifically in
the early embryonic heart (E8.5) and is downstream in the
Nkx2-5 pathway that defines the early heart field (Zou et
al., 1997). In the adult heart, CARP is developmentally
downregulated, but can be dramatically induced as part of
the onset of an embryonic gene program during cardiac
hypertrophy (Arber et al., 1997; Kuo et al., 1999). Further-
more, CARP expression is induced during denervation of
skeletal muscle (Baumeister et al., 1997) and by stimuli
such as the muscle toxin adriamycin (doxorubicin) (Jeya-
seelan et al., 1997). In summary, these studies reveal that
CARP is involved in the regulation of muscle gene expres-
sion, physiologically during development and pathologi-
cally in response to various cellular stresses.
Here, using a novel affinity-purified CARP-specific anti-
body (Fig. 6 B), an intranuclear localization of CARP was
confirmed. However, high levels of CARP staining were
also detected in the cytoplasm, as a sarcomeric bound form
in the central I-band. The discovery of this large propor-
tion of CARP that is associated with sarcomeric I-bands is
likely to provide insights into understanding regulation of
CARP-based signaling, since free CARP presumably is
rapidly degraded by PEST-directed proteases (Baumeister
et al., 1997) whereas I-band bound CARP may be more
stable. Interestingly, in some myocytes, we detected only
sarcomeric CARP. In other myocytes nuclear CARP was
predominant, whereas in still others both localization pat-
terns were detected. This suggests that CARP may be dy-
namically redistributed between sarcomeres and nuclei. In
this respect, our immunolocalization results for CARP are
similar to those obtained for myopalladin: myopalladin
was also detected in variable amounts inside the nucleus,
but also as a sarcomeric bound form both at the Z-line pe-
riphery and in the central I-band region where CARP is
colocalized. Myopalladin contains a potential nuclear im-
port signal in its sequence (KKPR, residues 486–489). It re-
mains to be seen if this motif is involved in nuclear import,
or if myopalladin can be imported into nuclei as a complex
with the nuclear form of CARP. Interestingly, our overex-
pression data demonstrated that the NH2-terminal region
of myopalladin containing the CARP-binding region, but
not the central region (containing the nebulin-binding re-
gion) or the COOH-terminal region (containing the a-acti-
nin–binding region), caused disruption of all sarcomeric
proteins studied (Figs. 9 and 10). These data suggest that
the interaction of myopalladin and CARP is critical forBang et al. Myopalladin Assemblies 427
sarcomeric structure in cardiac myocytes. Clearly, future
studies are required to investigate the molecular basis for
the targeting of myopalladin and CARP to multiple cellu-
lar sites, and how these dynamic redistributions are in-
volved in myofibril assembly, muscle structure, and muscle
gene expression.
The further biochemical characterization of myopalla-
din, that is, its interaction with molecules crucially in-
volved in Z-line assembly (a-actinin and nebulin/nebu-
lette) and in muscle gene expression regulation (CARP),
together with an understanding of its multiple cellular lo-
calizations, may provide insights into how myofibril as-
sembly/disassembly and gene expression regulatory mech-
anisms are linked.
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